Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan + amlodipine vs allisartan isoproxil + amlodipine in essential hypertension
ChiCTR2600127558Phase 4Completed
- Sponsor
- Ruijin Hospital
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in essential hypertension comparing Azilsartan + amlodipine arm with Allisartan isoproxil + amlodipine arm (2 arms). Primary endpoint: Mean seated office systolic blood pressure (msSBP). Started Jul 2026; status: completed.
02
Drugs
azilsartanamlodipineallisartan isoproxil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR2600127558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127558.